Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BCL7A Antikörper (Middle Region)

BCL7A Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN632338
  • Target Alle BCL7A Antikörper anzeigen
    BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
    Bindungsspezifität
    • 15
    • 8
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Middle Region
    Reaktivität
    • 34
    • 8
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Human
    Wirt
    • 33
    • 1
    Kaninchen
    Klonalität
    • 34
    Polyklonal
    Konjugat
    • 17
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BCL7A Antikörper ist unkonjugiert
    Applikation
    • 27
    • 18
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Spezifität
    BCL7 A antibody was raised against the middle region of BCL7
    Aufreinigung
    Affinity purified
    Immunogen
    BCL7 A antibody was raised using the middle region of BCL7 corresponding to a region with amino acids QENSSNSSPAPEPNSAVPSDGTEAKVDEAQADGKEHPGAEDASDEQNSQS
    Top Product
    Discover our top product BCL7A Primärantikörper
  • Applikationshinweise
    WB: 1 µg/mL
    Optimal conditions should be determined by the investigator.
    Kommentare

    BCL7A Blocking Peptide, catalog no. 33R-7534, is also available for use as a blocking control in assays to test for specificity of this BCL7A antibody

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BCL0 antibody in PBS
    Konzentration
    Lot specific
    Buffer
    PBS
    Handhabung
    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
  • Target
    BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
    Andere Bezeichnung
    BCL7A (BCL7A Produkte)
    Synonyme
    BCL7 antikoerper, cb585 antikoerper, id:ibd1097 antikoerper, sb:cb585 antikoerper, wu:fk02d01 antikoerper, zgc:92023 antikoerper, 4432415N06Rik antikoerper, AI448316 antikoerper, bcl7a antikoerper, MGC89576 antikoerper, BCL7A antikoerper, BCL tumor suppressor 7A antikoerper, B-cell CLL/lymphoma 7A antikoerper, B cell CLL/lymphoma 7A antikoerper, B-cell CLL/lymphoma 7A L homeolog antikoerper, BCL7A antikoerper, bcl7a antikoerper, Bcl7a antikoerper, bcl7a.L antikoerper
    Hintergrund
    This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma.
    Molekulargewicht
    25 kDa (MW of target protein)
Sie sind hier:
Kundenservice